InnoCare Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SEHK:9969 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
18 Aug 25	SellHK$24,998,677	Kee Chan Pang	Individual	1,498,120	HK$16.69
05 Aug 25	SellHK$16,834,008	AEGON-Industrial Fund Management Co. Ltd.	Company	892,639	HK$18.86
10 Jul 25	BuyHK$19,988,238	AEGON-Industrial Fund Management Co. Ltd.	Company	1,452,000	HK$13.77
10 Jun 25	SellHK$98,751,462	Kee Chan Pang	Individual	8,810,642	HK$11.21
22 May 25	SellHK$17,207,205	The Goldman Sachs Group, Inc.	Company	1,570,000	HK$10.96

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 9969?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	8,975,521	0.529%
VC/PE Firms	293,724,340	17.3%
Individual Insiders	325,417,742	19.2%
Institutions	397,228,153	23.4%
General Public	670,582,668	39.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 57.6% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.3%	Hillhouse Investment Management, Ltd.	208,671,222	HK$2.7b	0%	1.35%
8.25%	Renbin Zhao	139,917,893	HK$1.8b	0%	no data
5.95%	Jisong Cui	100,951,416	HK$1.3b	0%	no data
5.02%	Vivo Capital, LLC	85,053,118	HK$1.1b	0%	7.26%
4.75%	Kee Chan Pang	80,523,433	HK$1.0b	-34.6%	no data
4.4%	AEGON-Industrial Fund Management Co. Ltd.	74,671,860	HK$972.8m	0%	0.69%
3.01%	The Goldman Sachs Group, Inc.	51,018,340	HK$664.7m	-1,290%	0.03%
2.84%	The Vanguard Group, Inc.	48,132,196	HK$627.1m	0.56%	no data
1.52%	GF Fund Management Co., Ltd.	25,773,075	HK$335.8m	0%	0.08%
1.2%	China Universal Asset Management Company Ltd.	20,378,910	HK$265.5m	0%	0.2%
1.2%	Penghua Fund Management Co., Ltd.	20,267,913	HK$264.1m	0%	0.27%
0.94%	Fullgoal Fund Management Co. Ltd.	15,998,368	HK$208.4m	0%	0.2%
0.88%	E Fund Management Co., Ltd.	14,947,390	HK$194.7m	0%	0.04%
0.88%	BlackRock, Inc.	14,911,384	HK$194.3m	7.44%	no data
0.62%	Norges Bank Investment Management	10,492,414	HK$136.7m	36.3%	no data
0.54%	Bosera Asset Management Co., Ltd.	9,192,000	HK$119.8m	0%	0.1%
0.53%	Guangzhou Economic Technology Development Zone Management Committee	8,975,521	HK$116.9m	0%	no data
0.51%	China International Capital Corporation Hong Kong Asset Management Limited	8,690,091	HK$113.2m	0%	1.95%
0.41%	Wanjia Asset Management Co., Ltd.	6,949,590	HK$90.5m	0%	0.41%
0.37%	Fidelity International Ltd	6,339,424	HK$82.6m	0%	no data
0.33%	China Asset Management Co. Ltd.	5,596,826	HK$72.9m	89.8%	0.01%
0.3%	Harvest Fund Management Co. Ltd.	5,024,883	HK$65.5m	0%	0.01%
0.29%	ABC-CA Fund Management Co., Ltd.	4,884,558	HK$63.6m	0%	0.32%
0.29%	Baoying Fund Management Co. Ltd.	4,871,058	HK$63.5m	0%	0.58%
0.28%	Dimensional Fund Advisors LP	4,694,628	HK$61.2m	0.01%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/03/05 16:43
End of Day Share Price	2026/03/05 00:00
Earnings	2025/09/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

InnoCare Pharma Limited is covered by 21 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Pei Cheng	China Galaxy Securities Co., Ltd.
Peng Zou	China International Capital Corporation Limited
Jin Zhang	China International Capital Corporation Limited